Ingrid Garberis

Title: Ingrid Garberis: Innovator in Breast Cancer Prognosis

Introduction

Ingrid Garberis is a notable inventor based in Paris, France. She has made significant contributions to the field of medical technology, particularly in breast cancer prognosis. Her innovative work focuses on utilizing machine learning to enhance predictive capabilities in cancer treatment.

Latest Patents

Ingrid holds 1 patent for her invention titled "Systems and methods for determining breast cancer prognosis and associated features." This patent describes a computer-implemented method and a machine learning model designed to predict the likelihood of relapse in breast cancer patients following treatment. Additionally, it includes the ability to predict tumors within whole slide images and assess biomarker status in breast cancer tissue.

Career Highlights

Throughout her career, Ingrid has worked with prominent companies in the medical technology sector, including Owkin France SAS and Owkin, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cancer prognosis.

Collaborations

Ingrid has collaborated with talented professionals in her field, including Charlie Saillard and Benoit Schmauch. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Ingrid Garberis is a pioneering inventor whose work in breast cancer prognosis exemplifies the intersection of technology and healthcare. Her contributions are vital in improving patient outcomes and advancing medical research.